OBJECTIVE Moderate weight gain is usual after starting insulin therapy. The identification
and quantification of factors associated with weight gain may help target strategies for …

Aims: Little information is available on the association between obesity at time of insulin
initiation and attainment of glycaemic targets in type 2 diabetic (T2DM) patients. This study …

OBJECTIVE The determinants of insulin-associated weight gain in type 2 diabetes mellitus
(T2DM) are partly unknown. Therefore, we conducted a prospective study to identify …

Background: An increase in body weight is a commonly perceived effect of insulin therapy
for type 2 diabetes mellitus, and this may serve as a barrier to insulin initiation and usage …

Aims To evaluate, in patients with type 2 diabetes (T2DM) treated with insulin, the extent of
weight gain over 2 years of insulin treatment, and the dynamics of weight gain in relation to …

OBJECTIVE Identify determinants of weight gain in people with type 2 diabetes mellitus
(T2DM) allocated to intensive versus standard glycemic control in the Action to Control …

Previous studies have suggested that weight gain is an identifiable risk of efforts to lower
blood glucose with intensive insulin therapy in type I (insulin-dependent) diabetic subjects …

Background: The effectiveness of insulin therapy to lower blood glucose levels in patients
with type 2 diabetes (T2D) may depend on a variety of factors. This study aims to determine …

BACKGROUND Limited community-based data describe weight change after diabetes
diagnosis. OBJECTIVE To evaluate weight change patterns and associations in the 1st year …

OBJECTIVE—There is a concern that an “epidemic of obesity” is occurring in Western
societies. One consequence of obesity is that type 2 diabetes may develop. Presumably, a …